Drug Database
Back to search

Japan· JP-7319002X1012

安息香酸ナトリウム

A sodium benzoate product containing 安息香酸ナトリウム, registered in Japan, on the national reimbursement list. The same ATC class is registered in 4 of our 19 countries.

On Japan’s NHI price listATC A16AX11

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalised安息香酸ナトリウムATCA16AX11REGISTER NO.JP-7319002X1012PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about 安息香酸ナトリウムAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Sodium benzoate is registered in 4 of 19 countries.

Countries holding a registration under ATC A16AX11 (sodium benzoate), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 1 of them publish a price we can compare per daily dose
Search sodium benzoate products by name

Sodium benzoate · ATC A16AX11

4 / 19 countries

  • Germany
  • Japan
  • Norwayprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
安息香酸ナトリウム
Manufacturer
—
Country
Japan (JP)
ATC code
A16AX11
ATC class
Sodium benzoate
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sodium benzoate in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sodium benzoate products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Germany · Natriumbenzoat Smartpractice Europe

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8d9ffc1c-2239-4bad-8886-f1146d9a4d13
GET /v1/drugs/8d9ffc1c-2239-4bad-8886-f1146d9a4d13?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "１０ｇ",
  "marks": "局",
  "source": "mhlw",
  "remarks": null,
  "yj_code": "7319002X1012",
  "category": "内用薬",
  "price_yen": null,
  "generic_name": "安息香酸ナトリウム",
  "product_name_jp": null,
  "therapeutic_class": "7319",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about sodium benzoate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console